©The Author(s) 2025.
World J Clin Oncol. Jan 24, 2025; 16(1): 94813
Published online Jan 24, 2025. doi: 10.5306/wjco.v16.i1.94813
Published online Jan 24, 2025. doi: 10.5306/wjco.v16.i1.94813
Table 4 Overall performance of the ovarian cancer immunotherapy efficacy model
| Discovery cohort | Validation cohort | |
| AUC | 0.9444 | 0.9167 |
| AUC 95%CI | 0.8333-1.0000 | 0.6667-1.0000 |
| Specificity | 1.0000 | 0.8333 |
| Sensitivity | 0.8889 | 1.0000 |
| Accuracy | 0.9444 | 0.8750 |
| NPV | 0.9000 | 1.0000 |
| PPV | 1.0000 | 0.6667 |
| P value, goodness of fit | 0.3708 | 0.1175 |
- Citation: Tang ZJ, Pan YM, Li W, Ma RQ, Wang JL. Unlocking the future: Mitochondrial genes and neural networks in predicting ovarian cancer prognosis and immunotherapy response. World J Clin Oncol 2025; 16(1): 94813
- URL: https://www.wjgnet.com/2218-4333/full/v16/i1/94813.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i1.94813